Scarborough Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.75K	Buy	+33	New	+$3.75K	﹤0.01%	312
2024 Q3	–	Sell	-33	Closed	-$2.78K	–	297
2024 Q2	$2.78K	Hold	33	–	–	﹤0.01%	287
2024 Q1	$2.41K	Hold	33	–	–	﹤0.01%	295
2023 Q4	$2.36K	Buy	+33	New	+$2.36K	﹤0.01%	557